Lisa Pham

(Bloomberg) -- Eli Lilly & Co.'s relentless stock records have Morgan Stanley analysts musing whether it will become the first US company outside of the Magnificent Seven to reach a market value of $1 trillion.

Zepbound, which was recently approved for weight loss, is predicted to become the best-selling drug in history

Companies should consider smaller portions, fresh ingredients or offloading unhealthy brands altogether as weight-loss drugs take off, respondents say.

London's shrinking stock market suffered a fresh setback after British drugmaker Indivior Plc said it could move its primary listing to the US.

(Bloomberg) -- Companies selling unhealthy foods need to tweak their business models to counter the growing popularity of weight-loss drugs — or risk alienating investors, according to the latest Bloomberg Markets Live Pulse survey.Most Read from BloombergCapital One to Buy Discover for $35 Billion in Year's Biggest Deal Largest Covid Vaccine Study Yet Finds Links to Health ConditionsYour 401(k) Will Be Gone Within a DecadeStocks Fall Before Nvidia’s Make-or-Break Moment: Markets WrapUS Tells Al

London's reputation has suffered amid an exodus of companies Hunt is due to present his budget to Parliament on March 6

Few signs of cooling in sector M&A after 46 deals during 2023 Big Pharma has plenty of firepower with $110 billion cash pile

Hi, it’s Lisa in London, where a recent trip to the sauna left me wondering whether it can lead to a long Covid crash. But before we get to that...

The FTSE 100 Index closed at a record high for the first time in more than a year, as recent equity market volatility and geopolitical risks prompted

The FTSE 100 Index closed at a record high for the first time in more than a year, as recent equity market volatility and geopolitical risks prompted investors to pile into the defensive sectors that characterize the UK benchmark.